Nuclear Medicine and Biology
Volume 36, Issue 1 , Pages 57-64 , January 2009

Detection of sites of infection in mice using 99mTc-labeled PN2S-PEG conjugated to UBI and 99mTc-UBI: a comparative biodistribution study

  • Laura Meléndez-Alafort

      Affiliations

    • Department of Pharmaceutical Sciences, University of Padua, 35131 Padova, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 049 827 5342; fax: +39 049 827 5366.
    • ,
  • Anna Nadali

      Affiliations

    • Department of Pharmaceutical Sciences, University of Padua, 35131 Padova, Italy
    • ,
  • Gianfranco Pasut

      Affiliations

    • Department of Pharmaceutical Sciences, University of Padua, 35131 Padova, Italy
    • ,
  • Elena Zangoni

      Affiliations

    • Department of Pharmaceutical Sciences, University of Padua, 35131 Padova, Italy
    • ,
  • Raffaele De Caro

      Affiliations

    • Department of Anatomy and Physiology, University of Padua, 35131 Padova, Italy
    • ,
  • Luca Cariolato

      Affiliations

    • Department of Pharmaceutical Sciences, University of Padua, 35131 Padova, Italy
    • ,
  • Maria Cecilia Giron

      Affiliations

    • Department of Pharmacology and Anesthesiology, University of Padua, 35131 Padova, Italy
    • ,
  • Ignazio Castagliuolo

      Affiliations

    • Department of Histology, Microbiology and Medical Biotechnologies, University of Padua, 35131 Padova, Italy
    • ,
  • Francesco M. Veronese

      Affiliations

    • Department of Pharmaceutical Sciences, University of Padua, 35131 Padova, Italy
    • ,
  • Ulderico Mazzi

      Affiliations

    • Department of Pharmaceutical Sciences, University of Padua, 35131 Padova, Italy

Received 9 July 2008 ,Revised 15 October 2008 ,Accepted 25 October 2008.

References 

  1. Buscombe JR. The future of infection imaging. Q J Nucl Med Mol Imag. 2006;50:99–103
  2. Nibbering PH, Welling MM, Paulusma-Annema A, Brouwer C, Lupetti A, Pauwels EKJ. Tc-99m-labeled UBI 29–41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med. 2004;45:321–326
  3. Thakur ML. Radiolabeled peptides — now and the future. Nucl Med Comm. 1995;16:724–732
  4. Welling MM, Mongera S, Lupetti A, Balter HS, Bonetto V, Mazzi U, et al. Radiochemical and biological characteristics of Tc-99m-UBI 29–41 for imaging of bacterial infections. Nucl Med Biol. 2002;29:413–422
  5. Melendez-Alafort L, Ramirez FD, Ferro-Flores G, de Murphy CA, Pedraza-Lopez M, Hnatowich DJ. Lys and Arg in UBI: A specific site for a stable Tc-99m complex?. Nucl Med Biol. 2003;30:605–615
  6. Ferro-Flores G, Ramirez FD, Melendez-Alafort L, de Murphy CA, Pedraza-Lopez M. Molecular recognition and stability of Tc-99m-UBI 29–41 based on experimental and semiempirical results. Appl Radiat Isot. 2004;61:1261–1268
  7. Saeed M, Iqbal J, Khan MA, Irfanullah J, Jehangir M, Khan B, et al. Tc-99m-labeled antimicrobial peptide ubiquicidin (29–41) accumulates less in Escherichia coli infection than in Staphylococcus aureus infection. J Nucl Med. 2004;45:849–856
  8. Ferro-Flores G, de Murphy CA, Pedraza-Lopez M, Melendez-Alafort L, Zhang YM, Rusckowski M, et al. In vitro and in vivo assessment of Tc-99m-UBI specificity for bacteria. Nucl Med Biol. 2003;30:597–603
  9. Melendez-Alafort L, Rodriguez-Cortes J, Ferro-Flores G, De Murphy CA, Herrera-Rodriguez R, Mitsoura E, et al. Biokinetics of Tc-99m-UBI 29–41 in humans. Nucl Med Biol. 2004;31:373–379
  10. Ferro-Flores G, de Murphy CA, Palomares-Rodriguez P, Melendez-Alafort L, Pedraza-Lopez M. Kit for instant Tc-99m labeling of the antimicrobial peptide ubiquicidin 29–41. J Radioanal Nucl Chem. 2005;266:307–311
  11. Welling MM, Korsak A, Gorska B, Oliver P, Mikolajczak R, Balter HS, et al. Kit with technetium-99m labelled antimicrobial peptide UBI 29–41 for specific infection detection. J Label Compd Radiopharm. 2005;48:683–691
  12. Sarda-Mantel L, Saleh-Mghir A, Welling MM, Meulemans A, Vrigneaud JM, Raguin O, et al. Evaluation of 99mTc-UBI 29–41 scintigraphy for specific detection of experimental Staphylococcus aureus prosthetic joint infections. Eur J Nucl Med Mol Imaging. 2007;34:1302–1309
  13. Akhtar MS, Qaisar A, Irfanullah J, Iqbal J, Khan B, Jehangir M, et al. Antimicrobial peptide Tc-99m-ubiquicidin 29–41 as human infection-imaging agent: Clinical trial. J Nucl Med. 2005;46:567–573
  14. Gemmel F, Dumarey N, Palestro CJ. Radionuclide imaging of spinal infections. Eur J Nucl Med Mol Imaging. 2006;33:1226–1237
  15. Welling MM, Visentin R, Feitsma HIJ, Lupetti A, Pauwels EKJ, Nibbering PH. Infection detection in mice using Tc-99m-labeled HYNIC and N2S2 conjugated to the antimicrobial peptide UBI 29–41. Nucl Med Biol. 2004;31:503–509
  16. Pasut G, Caboi F, Schrepfer R, Tonon G, Schiavon O, Veronese FM. New active poly(ethylene glycol) derivative for amino coupling. React Funct Polym. 2007;67:529–539
  17. Pasut G, Veronese FM. Polymer–drug conjugation, recent achievements and general strategies. Prog Polym Sci. 2007;32:933–961
  18. Veronese FM, Pasut G. PEGylation, successful approach to drug delivery. Drug Discov Today. 2005;10:1451–1458
  19. Visentin R, Pasut G, Veronese FM, Mazzi U. Highly efficient technetium-99m labeling procedure based on the conjugation of N-[N-(3-diphenylphosphinopropionyl)-glycyl]cysteine ligand with poly(ethylene glycol). Bioconjugate Chem. 2004;15:1046–1054
  20. Maini C, de Notaristefani F, Tofani A, Incopi F, Sciuto R, Semprebene A, et al. 99mTc-MIBI scintimammography using a dedicated nuclear mammograph. J Nucl Med. 1999;40:46–51
  21. Snyder SL, Sobocinski BZ. An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines. Anal Biochem. 1975;64:284–288
  22. Caliceti P, Veronese FM. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates. Adv Drug Deliv Rev. 2003;55:1261–1277

PII: S0969-8051(08)00235-7

doi: 10.1016/j.nucmedbio.2008.10.011

Nuclear Medicine and Biology
Volume 36, Issue 1 , Pages 57-64 , January 2009

Article Tools

* Image Usage & Resolution